Fig. 1
Distribution of treatment location according to the bone substitute; all cases in each group (allogeneic cancellous bone [ACB] or synthetic bone substitute [SBS]) amount to 100Â %. Exact numbers are stated in the figure
Fig. 1 | BMC Musculoskeletal Disorders